Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
96.333,68
-0,90%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Alpha Tau Medical Ltd (DRTSW) Alpha Tau Medical Ltd (DRTSW) Notizie

Alpha Tau Medical Ltd

DRTSW
0,32
0,1095 (52,02%)
20 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Warrant Azionario
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/12/202414:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/12/202414:30GLOBEAlpha Tau Announces Upcoming Presentation of New Data at..
17/12/202415:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/12/202415:00GLOBEAlpha Tau Announces Appointment of Maya Netser to its Board..
17/12/202414:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202414:30GLOBEAlpha Tau to Present at the 43rd Annual J.P. Morgan..
06/12/202414:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202414:30GLOBEAlpha Tau to Participate in Ladenburg’s Oncology Innovators..
19/11/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/11/202422:00GLOBEAlpha Tau Medical Announces Third Quarter 2024 Financial..
13/11/202414:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202414:30GLOBEAlpha Tau to Participate in Citi’s 2024 Global Healthcare..
21/10/202414:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/10/202414:30GLOBEAlpha Tau Announces Acceptance Into FDA’s Total Product Life..
10/10/202414:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202414:30GLOBEAlpha Tau Treats First Patient with Recurrent Lung Cancer
20/9/202414:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/9/202414:30GLOBEAlpha Tau Announces FDA Approval of IDE to Initiate..
22/8/202414:30GLOBEAlpha Tau to Participate in the H.C. Wainwright 26th Annual..
14/8/202422:02GLOBEAlpha Tau Medical Announces Second Quarter 2024 Financial..
25/6/202414:30GLOBEAlpha Tau Announces Publication in Cancers Journal of..
21/5/202414:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/5/202414:45GLOBEAlpha Tau to Present at the Jefferies Global Healthcare..
20/5/202422:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/5/202422:01GLOBEAlpha Tau Medical Announces First Quarter 2024 Financial..
13/5/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/5/202414:30GLOBEAlpha Tau Announces Alpha DaRT Treatment of First Patient..
06/5/202414:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/5/202414:30GLOBEAlpha Tau Presents Preclinical Data Demonstrating Abscopal..
01/5/202414:30GLOBEAlpha Tau to Participate in May Investor Conferences
25/3/202413:50GLOBEAlpha Tau to Present at the Jefferies Radiopharma Innovation..
07/3/202422:01GLOBEAlpha Tau Medical Announces Full Year 2023 Financial Results..
26/2/202414:30GLOBEAlpha Tau to Participate in Barclays 26th Annual Global..
Apertura: 0,2105 Min: 0,21 Max: 0,32
Chiusura: 0,2105

La tua Cronologia

NASDAQ
DRTSW
Alpha Tau Medical
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network